Clinical Trial Update: Pentaglobin in CRE and PA Neutropenic Infections [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Pentaglobin in neutropenic infections due to CRE and Pseudomonas aeruginosa in septic shock; the study is active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Pentaglobin (IgM-enriched polyclonal immunoglobulin)

Snippet

Sponsor: Gruppo Italiano Trapianto di Midollo Osseo | Conditions: Septic Shock | Phase 2 | Status: ACTIVE_NOT_RECRUITING